Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news


MSD bumps up baby policy

Posted 23 February 2021 AM

MSD has boosted its parental leave policy recognising that mums and dads come "in all shapes and sizes" and helping them to strike a better balance between work and home makes smart business sense.

Under the changes, the company has scrapped the traditional 12-month waiting period for parental leave, stretched the time employees can take leave until their child turns two and made leave 'caregiver status neutral' to include surrogacy, adoption and other caring arrangements.

Looks like you've lost your access to Pharma in Focus. To restore access or update your subscription, click here

Approvals Action
Pfizer vs Humira
Adds to a growing list of adalimumab biosims
Top of the Hill
How not to reform the PBAC
In the face of deep change, is piecemeal enough?
Special Report
Aust Covid Vaccine Tracker
UPDATE: Distribution of two mRNA vaccines overseas